C magnetic resonance spectroscopy (MRS), to measure pH i in the healthy and diseased heart.
Methods and results
Hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate was infused into isolated rat hearts before and immediately after ischaemia, and the formation of 13 CO 2 and H 13 CO 3 2 was monitored using 13 C MRS. The HCO 3 2 /CO 2 ratio was used in the Henderson-Hasselbalch equation to estimate pH i . We tested the validity of this approach by comparing 13 C-based pH i measurements with 31 P MRS measurements of pH i . There was good agreement between the pH i measured using 13 C and 31 P MRS in control hearts, being 7.12 + 0.10 and 7.07 + 0.02, respectively. In reperfused hearts, 13 C and 31 P measurements of pH i also agreed, although 13 C equilibration limited observation of myocardial recovery from acidosis. In hearts pre-treated with the carbonic anhydrase (CA) inhibitor, 6-ethoxyzolamide, the 13 C measurement underestimated the 31 P-measured pH i by 0.80 pH units. Mathematical modelling predicted that the validity of measuring pH i from the H 13 CO 3 2 / 13 CO 2 ratio depended on CA activity, and may give an incorrect measure of pH i under conditions in which CA was inhibited, such as in acidosis. Hyperpolarized [1-
Introduction
The rapid onset of acidosis is a well-documented characteristic of myocardial ischaemia. 1, 2 Under poor coronary perfusion, anaerobic glycolysis increases in the heart, producing intracellular protons and lactic acid that accumulate in the intra-and extracellular spaces. 3 Some of the acid reacts with HCO 3 2 to form CO 2 , which adds to any CO 2 generated by residual oxidative metabolism. Accumulation of protons, lactic acid, and CO 2 in the ischaemic heart decreases intracellular pH (pH i ) from normal levels of around 7.1-7.2. 1,2 Transient acidosis during ischaemia may be beneficial, as it decreases the major adenosine triphosphate (ATP) consumer, contractility, and thus conserves ATP for ion transport. 4 However, the ATP reduction caused by severe and sustained ischaemia decreases Na þ ,K þ -ATPase activity, which increases myocardial Na þ levels. Increased Na þ inhibits Ca 2þ extrusion via the Na þ /Ca 2þ exchanger, thus elevating myocardial Ca 2þ and damaging the myocardium. 5 
31
P magnetic resonance spectroscopy (MRS) has long been the gold standard for pH i measurement in the isolated perfused heart, 6 based on the chemical shift of the inorganic phosphate (P i ) peak. 7, 8 However, 31 P MRS cannot measure cardiac pH i in vivo, because 2,3-diphosphoglycerate (2,3-DPG) in the ventricular blood contaminates the myocardial P i peak. 6, 9, 10 The pH-dependent equilibrium between bicarbonate and CO 2 has been used to measure extracellular pH (pH o ) non-invasively in tumours. 11 By infusing hyperpolarized 13 C-bicarbonate intravenously, MR was used to image the distribution of hyperpolarized bicarbonate and CO 2 and a pH map was generated using the Henderson-Hasselbalch equation:
where pK a is the acid-dissociation constant of CO 2 , which is 6.15 in the Krebs-Henseleit buffer. 12 For correct application of the Henderson-Hasselbalch equation, the following two conditions must be met: (i) 13 CO 2 to H 13 CO 3 2 exchange kinetics, catalysed by carbonic anhydrase (CA), must be rapid and (ii) 13 CO 2 and H 13 CO 3 2 signals must be detected simultaneously from the same cellular compartment.
In tumours, the Henderson-Hasselbalch equation was applied correctly because of the high CA activity on the surface of tumour cells 13 and within erythrocytes, 14 and the slow, transporter-mediated, cellular uptake of infused bicarbonate.
15
A similar approach may be useful for measuring pH i in the in vivo heart. 16, 17 Infusion of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate results in mitochondrial production of hyperpolarized 13 CO 2 by pyruvate dehydrogenase (PDH, Figure 1) . 18 Hyperpolarization by the dynamic nuclear polarization method increases the 13 C MR sensitivity of pyruvate, and other 13 C-labelled metabolites, more than 20 000-fold. 19 Further, when a hyperpolarized metabolite is infused into tissue, the high-sensitivity 13 C label is transferred to the tracer's metabolic products, enabling unprecedented real-time visualization of the biochemical mechanisms of normal and abnormal metabolism. Only metabolic processes that occur rapidly can be monitored using hyperpolarized 13 C MR methods because the hyperpolarized signal decays to thermal equilibrium according to its inherent spin -lattice relaxation time (in the case of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Figure 1 , metabolically generated CO 2 diffuses rapidly from its site of production into the cytosol, and subsequently into the extracellular space. 20 Measuring cardiac intracellular pH using hyperpolarized metabolites
The aim of the present study was to evaluate the potential of hyperpolarized 13 C MR for the non-invasive measurement of pH i in the heart. We measured PDH flux and the production of 13 Krebs -Henseleit bicarbonate perfusion buffer contained 1.2 mM inorganic phosphate (KH 2 PO 4 ), 11 mM glucose, and 2.5 mM pyruvate and was aerated with a mixture of 95% oxygen (O 2 ) and 5% carbon dioxide (CO 2 ) to give a final pH of 7.4 at 378C. The broad-spectrum CA inhibitor, 6-ethoxyzolamide (ETZ), was dissolved in dimethyl sulfoxide (DMSO) and added to the perfusate to achieve a final concentration of 100 mM (with DMSO , 0.01% of total buffer volume). ETZ was expected to evenly distribute throughout the intra-and extracellular spaces to inhibit all cardiac CA isoforms. 20 Unless specified, compounds were obtained from Sigma (Gillingham, UK). For further details of the Langendorff heart perfusion method, see Supplementary material online, S1.
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Experimental protocols 2.2.1 Control protocol
Isolated hearts (n ¼ 6) were perfused for 30 min at 85 mmHg. For the initial 20 min, 31 P MRS was used to measure pH i . After this, hyperpolarized [1-
13
C]pyruvate was infused and the progress of 13 C-labelled compounds was followed using 13 C MRS.
Inhibition of CA
Hearts (n ¼ 5) were perfused for 30 min. After 10 min of perfusion in normal buffer, the hearts were switched to buffer containing 100 mM ETZ. 31 P MRS was performed for 20 min (10 min before and 10 min after switch over to ETZ-containing buffer). Ten minutes after the start of ETZ perfusion, hyperpolarized [1-13 C]pyruvate was infused and MRS was switched from 31 P to 13 C.
Reperfusion following ischaemia
Hearts (n ¼ 12) were perfused for 30 min, followed by 10 min of total, global ischaemia, and 15 min reperfusion.
31
P MRS spectra were acquired for 20 min immediately before and 9 min during ischaemia. Hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate was infused immediately after ischaemia, such that hearts were reperfused with hyperpolarized tracer. In some hearts (n ¼ 6), 31 P MRS was performed throughout the reperfusion period. In other hearts (n ¼ 6), 13 C MRS was performed for 2 min during initial reperfusion with hyperpolarized [1- 
Magnetic resonance spectroscopy
31
P MR spectra were acquired at 202.5 MHz using a 308 radiofrequency (RF) pulse and a repetition delay of 0.25 s. The phosphocreatine (PCr) resonance was set at 0 ppm and the chemical shifts of all peaks were referenced to that of PCr. Each spectrum consisted of 120 transients, giving a total acquisition time of 30 s. As these partially saturated spectra had shorter repetition times than the longitudinal relaxation time of 31 P nuclei, an unsaturated spectrum was initially acquired from the hearts using a 908 pulse with repetition time of 15 s and 40 transients, and an acquisition time of 10 min. The unsaturated spectra were used to correct metabolite concentrations for the effects of saturation.
Acquisition of 13 
Data analysis 2.4.1 Carbon-13
Cardiac 13 C MR spectra were analysed using the AMARES algorithm, as implemented in the jMRUI software package. 26 Spectra were DC offset corrected based on the last half of acquired points and peaks corresponding with [1-
13
C]pyruvate and its metabolic derivatives were fitted assuming a Lorentzian line shape, initial peak frequencies, relative phases, and linewidths.
For spectra acquired from perfused rat hearts, the maximum peak area of each metabolite over the 2 min of acquisition was determined for each series of spectra and expressed as a percentage of the maximum [1- 13 C]pyruvate resonance. 18 The rate of signal production for each metabolite, in percent per second (%/s), was measured as the slope of the mean metabolite increase over the first 5 s following its appearance, over which time the metabolite signal increased linearly. Additionally, a first-order exponential signal decay term was fit to each metabolite peak from the point of maximum signal over the course of signal decay. Decay of the hyperpolarized signal depends on the intrinsic spin -lattice relaxation of the nucleus, production and consumption rates of the metabolite, and metabolite washout, and may therefore provide information about metabolite accumulation in the states of no-flow ischaemia and CA inhibition. 
The output of Eq. (2) is a variable pR which should, under the two conditions outlined in Section 1, measure pH. Upon the initial arrival of [1-
13 C]pyruvate, the relative proportions of 13 steady-state value. The calculated pR was fit to a first-order exponential equation to determine the steady-state value and time constant.
Phosphorus-31
Cardiac 31 P MR spectra were analysed using the AMARES algorithm in the jMRUI software package. 26 Spectra were corrected for DC offset using the last half of acquired points. The PCr, P i , a-, b-, and g-ATP resonances were fitted assuming a Lorentzian line shape, peak frequencies, relative phases, linewidths, and J-coupling parameters. pH i was calculated from the P i chemical shift. 8, 27 Absolute 31 P metabolite concentrations were calculated using an ATP concentration of 10.6 mM from the first g-ATP peak area 28 and expressing all other ATP and PCr peak areas relative to this area. 27 
Modelling
A system of ordinary differential equations was formulated to test the suitability of using the CO 2 -HCO 3 2 equilibrium to measure pH i . For details of the mathematical model, see Supplementary material online, S4.
Statistical methods
Data are given as mean + standard error. Statistical significances between pre-and post-ischaemic groups, and pre-ischaemic and ETZ-perfused groups, were assessed using a paired Student's t-test. Statistical significance was considered at P , 0.05.
Results
Myocardial energetics
Cardiac function and 31 P MR spectra were characteristic of the isolated rat heart during pre-ischaemia, ischaemia, and reperfusion. 1 A description of cardiac function throughout the protocol and an example of a 31 P spectrum of a heart before ischaemia are shown in Supplementary material online, S5. Pre-ischaemia, the average [ATP] was 10.6 + 0.7 mM and [PCr] was 19.7 + 0.9 mM (Figure 2) . Two minutes after stopping coronary flow, [PCr] decreased to 3.2 mM, to remain at 1.1 -2.1 mM for the remainder of ischaemia. The rate of [ATP] hydrolysis during ischaemia was 0.14 + 0.10 mM/ min. Five minutes after reperfusion, PCr had recovered to 17.6 + 1.9 mM, whereas ATP remained at 8.2 + 2.5 mM.
Perfusion with ETZ had no effect on [ATP] or [PCr] throughout the perfusion protocol (data not shown). Prior to ETZ perfusion, hearts had an average PCr of 17.8 + 1.9 mM and ATP of 10.6 + 0.5 mM. During ETZ perfusion, the average [PCr] was 18.0 + 1.5 mM and [ATP] was 10.3 + 0.9 mM.
PDH flux
A representative spectrum of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate in the perfused heart, and the typical kinetic progression of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate metabolites, is shown in Figure 3 . CO 2 production was 54% slower upon reperfusion, compared with the pre-ischaemic myocardium, as indicated by the slope of the reperfusion peaks shown in Figure 4 . Additionally, the decay rate of hyperpolarized 13 CO 2 signal was 30% faster in reperfused hearts than in pre-ischaemic hearts (P , 0.001), indicating enhanced CO 2 washout upon re-flow after ischaemia.
ETZ had no significant effect on the initial rate of H 13 CO 3 2 plus 13 CO 2 production, or the maximum peak area of the sum of H 13 CO 3 2 and 13 CO 2 , compared with pre-ischaemic hearts ( Figure 4) . However, ETZ increased the maximum 13 CO 2 peak area by four-fold, whereas decreasing the maximum H 13 CO 3 2 peak area by two-fold ( Table 1 , P , 0.001). Additionally, the decay rate of hyperpolarized 13 CO 2 signal was 19% faster in reperfused hearts than in pre-ischaemic hearts (P , 0.05), possibly indicating enhanced CO 2 diffusion out of myocytes in the absence of CA activity. Figure 5A shows the changes in H Figure 2 Changes in ATP, PCr, P i , and pH i , before, during, and after ischaemia. ATP levels gradually decreased during ischaemia, and after reperfusion, partially recovered to pre-ischaemia levels. PCr levels rapidly decreased at the onset of ischaemia and rapidly recovered to pre-ischaemic levels after reperfusion. P i levels rapidly increased at the onset of ischaemia and rapidly decreased to pre-ischaemic levels after reperfusion. pH i gradually decreased from 7.07 to 6.49 during ischaemia and rapidly recovered to preischaemia levels following reperfusion.
Measurement of pH i in the isolated perfused heart
Measuring cardiac intracellular pH using hyperpolarized metabolites calculation of pR. When hyperpolarized [1- 13 C]pyruvate reached the isolated heart, metabolically generated H 13 CO 3 2 and 13 CO 2 were out of equilibrium for 5 s before pR [Eq. (2)] reached a steady-state value of 7.12 + 0.10 ( Figure 5B ). Fully relaxed 31 P measurements, acquired in the pre-ischaemic heart, gave a pH i of 7.07 + 0.02. The pH i measured using 31 P MRS and the 95% confidence interval are overlaid on the 13 C results in Figure 5B .
31
P MRS confirmed that CA inhibition with ETZ had no effect on steady-state myocardial pH i (pH i of 7.02 + 0.03 before ETZ treatment and 7.00 + 0.04 after ETZ treatment). Figure 5D ). Thus, inhibition of CA activity slowed CO 2 -HCO 3 2 conversion, as shown by the lengthening of the out-of-equilibrium period, but also by the steady-state pR which was 0.79 pH units below the pH i measured using 31 P MRS. In reperfused hearts, 31 P MRS revealed that pH i recovered from a value of 6.49 + 0.04 at the end of ischaemia to 7.04 + 0.13, at a rate of 0.73 pH units/min during the 45 s immediately after reflow ( Figure 6 ). In hearts reperfused with hyperpolarized [1- Figure 6 ).
Mathematical modelling of experimental results
Results of the mathematical model of 13 CO 2 production, efflux, and hydration to H 13 CO 3 2 by CA are depicted in Figure 7 . Figure 7A shows the output of the model that best-fits the experimental data presented in Figure 5 . Figure 7B shows the value of pR [Eq. (2)] derived from the simulations in Figure 7A . At normal CA activity (g ¼ 10), pR approached 6.8 within 17 s, giving a reasonable approximation to the real pH i of 7.1. However, in the absence of CA activity (g ¼ 1), pR approached a significantly lower asymptote of 6.1 within 24 s.
Apart from CA activity, another factor that can disturb the equilibrium between H þ , HCO 3 2 and CO 2 is HCO 3 2 transport. Figure 7C and D illustrates the implications of HCO 3 2 extrusion and uptake, respectively, on the steady-state value of pR. In the presence of +5 mM/min transmembrane HCO 3 2 flux, the value of pR was not greatly altered, compared with a model with no net HCO 3 2 transport. Further modelling explored the relationship between pH i and the steady-state pR ( Figure 7E ) and the time required for equilibration ( Figure 7F) , measured as the time taken for pR to approach steady-state pR within 0.05 U. As CA activity (g) was increased, steady-state pR approached the true pH i and did so with a smaller time delay. For low values of CA (g , 10), pR significantly underestimated pH i . Moreover, for values of CA , 10, the time taken for pR to attain steady state was 10 -20 s, a significant fraction of the life-time of hyperpolarized 13 C compounds 25 and the time of pH i recovery following ischaemia.
Measurement of pH i in vivo
A representative spectrum of [1-
13
C]pyruvate infused in vivo is shown in Figure 8A . The H 13 CO 3 2 was observed with a signal-to-noise ratio (SNR) of 9.6 + 1.1, whereas the 13 CO 2 peak had an SNR of 1.2 + 0.1 and was thus at the limit of detectable signal. Therefore, to calculate pR, 1 s in vivo spectra were averaged in groups of two to yield a set of spectra with 2 s temporal resolution and the SNR improved to 16.9 + 3.5 and 2.0 + 0.4 for H 13 CO 3 2 and 13 CO 2 , respectively. Using the averaged spectra, pR reached a steady-state value of 7.20 + 0.03, as shown in Figure 8B .
Discussion
PDH flux before and after ischaemia
To study the CO 2 /HCO 3 2 equilibrium, PDH flux must be sufficient to generate MR-detectable levels of 13 CO 2 . Therefore, our first aim was to determine the effect of ischaemia on pyruvate oxidation. Others have studied PDH flux upon reperfusion of the ischaemic myocardium, with diverse results depending on the ischaemic model and the perfusion conditions. 17,24,29 -31 Kobayashi and Neely 29 observed that pyruvate plus glucose perfusion largely maintained PDH activity in the isolated reperfused heart, and in vivo PDH activity was maintained following reduction of coronary flow in swine. 32 However, in the isolated rat heart perfused with pyruvate alone or pyruvate and fatty acids, ischaemia decreased PDH activity and glucose oxidation for several minutes following reperfusion. 17, 30, 31 Here, 10 min of total global ischaemia decreased the rate of production of H CO 2 ratio in the isolated perfused rat heart, and in the in vivo rat heart, into a variable, pR, using the Henderson-Hasselbalch equation. At steady-state, pR in the isolated perfused rat heart was 7.12 + 0. 
Data are expressed means + SEM. All metabolite levels, and initial production rates, are expressed as a percentage of maximum [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate signal. Significant difference from pre-ischaemic hearts: *P , 0.05 and † P , 0.001. Figure 4 Comparison of the time courses for the sum of the bicarbonate and carbon dioxide peaks, normalized to the maximum value of pyruvate peak area. The maximum peak area did not change following either intervention, compared with the control. Following ischaemia, the initial slope of the curve was significantly reduced.
Measuring cardiac intracellular pH using hyperpolarized metabolites each measurement, to the pH i of 7.07 + 0.02 measured using 31 P MRS. When measured in rat hearts in vivo, pR was 7.20 + 0.03. These values are similar to those of Merritt et al., 17 and with pH i measured by others using 31 P MRS. 8 -10,20,28 Thus, hyperpolarized [1-13 C]pyruvate can be used to obtain an accurate, non-invasive measurement of cardiac pH i in vivo in healthy hearts. 17 As a first test of the suitability of pR to measure pH i , we inhibited cardiac CA activity in perfused rat hearts, without altering pH i . We found a significant difference between the steady-state pR of 6.21 and the pH i of 7.01 determined using 31 P MRS. Low pH i , such as that observed during myocardial ischaemia, inhibits CA activity. 22, 23 CO 2 ratio would not be a good measure of pH i in the ischaemic/reperfused heart without correction for low CA activity.
By modelling our H 13 CO 3 2 and 13 CO 2 results, we identified the conditions in which pR was not a valid measure of pH i . Provided that sufficient 13 CO 2 is generated via PDH flux, factors that alter the rate of CO 2 production (P pyr , r) will not alter steady-state pR. Likewise, CO 2 efflux (P CO 2 ) does not affect steady-state pR when the heart is perfused to the extent that extracellular 13 CO 2 is washed away rapidly. Changes to CO 2 permeability will alter CO 2 and HCO 3 2 levels in parallel and will not affect steady-state pR.
A discrepancy between pR and pH occurred with changes in the rate of CO 2 hydration and events related to HCO 3 2 and H þ . The rate of CO 2 hydration depends on CA activity. CA activity in cardiac myocytes is modest 21 and, furthermore, CA is inhibited by low pH i 22,23 and by pharmacological membrane-transport inhibitors. 33 Consequently, CO 2 hydration kinetics have an impact on the suitability of pR as a measure of pH i . The importance of CA activity was tested using a mathematical model (Figure 7) . At low CA activity, pR attained a steady-state that could be very different from pH i , and the equilibration time could be a significant fraction of the lifetime of hyperpolarized 13 C or of recovery from ischaemia-induced acidosis. Figure 7C and D). The error due to HCO 3 2 transport was, however, negligible and is therefore too slow to significantly affect CO 2 /HCO 3 2 equilibrium.
Limitations of the study
To measure pH i using [ Measuring cardiac intracellular pH using hyperpolarized metabolites A second limitation of this study is the fact that the hyperpolarized label cannot directly distinguish between metabolites located in the intra-and extracellular spaces. We can be certain that due to high cardiac oxidative rates, which are more than an order of magnitude higher than any neighbouring tissue (i.e. liver, resting skeletal muscle, adipose tissue, diaphragm, or blood), virtually all of the detected H 
Significance of this work
Currently, the non-invasive measurement of cardiac pH i in humans is impossible, because blood 2,3-DPG signal overlies the myocardial P i signal. 6 Since acidosis is a characteristic feature of ischaemia, assessment of ischaemic heart disease in humans is another potentially useful application of a non-invasive pH i calculation using the H 13 CO 3 2 / 13 CO 2 ratio. We observed excellent agreement between pH i measured using 31 P MRS and pR measured using 13 C MRS in the reperfused myocardium when pH i was !6.74 ( Figure 6 ). However, multiple factors shift pR relative to pH i , including inhibition of CA activity at low pH i 22,23 and stimulation of membrane transport during reperfusion following ischaemia. 2, 36 Pharmaceutical agents, such as cariporide, inhibit membrane ion transport and have been used clinically to reduce ischaemia-reperfusion injury, 37 but also block CA. 33 Therefore, the use of the H 13 CO 3 2 / 13 CO 2 ratio to measure pH i may not be valid in ischaemic, acidic hearts, and in patients with ischaemic heart disease who use drugs that inhibit membrane ion transport. Additionally, it is reasonable to expect that intracellular CA expression and activity may be either reduced or increased in other forms of cardiomyopathy. 35 Correction of pR to pH i will require CO 2 with relatively high spatial resolution across the area at risk will be required. The feasibility of acquiring such data across the myocardium of large animals, and therefore patients, has been demonstrated. 34 Further, although the eventual cost of clinical application of the hyperpolarized 13 C MR technology is not clear, it does not appear set to be prohibitive. Clinical polarizers could be operated as standalone systems, placed within existing clinical MR facilities and interfaced to existing MR scanners. Further, the cost of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvic acid, as used here, is not excessive and would be in line with contrast agents used in other imaging modalities, such as positron emission tomography.
In summary, we have demonstrated in the perfused heart that the H 
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